Endomorphin-2 inhibits GABAergic inputs to cardiac parasympathetic neurons in the nucleus ambiguus

Neuroscience

Volumn 113, Issue 4, 2002, Pages 975-983

  Venkatesan, P ^a   Wang, J ^a   Evans, C ^a   Irnaten, M ^a   Mendelowitz, D ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Endomorphin; Heart rate; Opiate; Opioid; Vagal

Indexed keywords

4 AMINOBUTYRIC ACID; ENDOMORPHIN 1; ENDOMORPHIN 2; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALOXONAZINE;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGY; EVOKED RESPONSE; GABAERGIC SYSTEM; INHIBITORY POSTSYNAPTIC POTENTIAL; NONHUMAN; NUCLEUS ACCUMBENS; PARASYMPATHETIC NERVE CELL; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ANIMALS; ANIMALS, NEWBORN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GAMMA-AMINOBUTYRIC ACID; HEART; NEURONS; OLIGOPEPTIDES; PARASYMPATHETIC FIBERS, POSTGANGLIONIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; RHOMBENCEPHALON; VAGUS NERVE;

EID: 0037056019     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00244-0     Document Type: Article

References (47)

1. Aicher, S.A., Mitchell, J.L., Sharma, S., Mendelowitz, D., 2001. Distribution of μ-opioid receptors in cardiac premotor neurons. Soc. Neurosci. Abstr. 27, 171.7.
2. Alreja M., Shanabrough M., Liu W., Leranth C. Opioids suppress IPSCs in neurons of the rat medial septum/diagonal band of Broca: involvement of mu-opioid receptors and septohippocampal GABAergic neurons. J. Neurosci. 20:2000;1179-1189.
3. Baba H., Kohno T., Okamoto M., Goldstein P.A., Shimoji K., Yoshimura M. Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal dorsal horn. J. Physiol. 508:1998;83-93.
4. Carrigan K.A., Nelson C.J., Lysle D.T. Endomorphin-1 induces antinociception without immunomodulatory effects in the rat. Psychopharmacology (Berl.). 151:2000;299-305.
5. Chiou L.C., Huang L.Y. Mechanism underlying increased neuronal activity in the rat ventrolateral periaqueductal grey by a mu-opioid. J. Physiol. 518:1999;551-559.
6. Chu X.P., Xu N.S., Li P., Wang J.Q. Endomorphin-1 and endomorphin-2, endogenous ligands for the mu-opioid receptor, inhibit electrical activity of rat rostral ventrolateral medulla neurons in vitro. Neuroscience. 93:1999;681-686.
7. Czapla M.A., Gozal D., Alea O.A., Beckerman R.C., Zadina J.E. Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine. Am. J. Respir. Crit. Care Med. 162:2000;994-999.
8. DiMicco J.A., Gale K., Hamilton B., Gillis R.A. GABA receptor control of parasympathetic outflow to heart: characterization and brainstem localization. Science. 204:1979;1106-1109.
9. Ding Y.Q., Kaneko T., Nomura S., Mizuno N. Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. J. Comp. Neurol. 367:1996;375-402.
10. Doi N., Brown C.H., Cohen H.D., Leng G., Russell J.A. Effects of the endogenous opioid peptide, endomorphin 1, on supraoptic nucleus oxytocin and vasopressin neurones in vivo and in vitro. Br. J. Pharmacol. 132:2001;1136-1144.
11. Eisenberg R.M. DAMGO stimulates the hypothalamo-pituitary-adrenal axis through a mu-2 opioid receptor. J. Pharmacol. Exp. Ther. 266:1993;985-991.
12. Hao S., Takahata O., Iwasaki H. Intrathecal endomorphin-1 produces antinociceptive activities modulated by alpha 2-adrenoceptors in the rat tail flick, tail pressure and formalin tests. Life Sci. 66:2000;L195-204.
13. Horvath G. Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous mu-opioid receptor agonists. Pharmacol. Ther. 88:2000;437-563.
14. Hugghins S.Y., Champion H.C., Cheng G., Kadowitz P.J., Jeter J.R. Jr. Vasorelaxant responses to endomorphins, nociceptin, albuterol, and adrenomedullin in isolated rat aorta. Life Sci. 67:2000;471-476.
15. Kamei J., Zushida K., Ohsawa M., Nagase H. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice. Eur. J. Pharmacol. 391:2000;91-96.
16. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19:1999;4544-4558.
17. Kondo S., Marty A. Differential effects of noradrenaline on evoked, spontaneous and miniature IPSCs in rat cerebellar stellate cells. J. Physiol. 509:1998;233-243.
18. Koyama S., Kubo C., Rhee J.S., Akaike N. Presynaptic serotonergic inhibition of GABAergic synaptic transmission in mechanically dissociated rat basolateral amygdala neurons. J. Physiol. 518:1999;525-538.
19. Lupica C.R. Delta and mu enkephalins inhibit spontaneous GABA-mediated IPSCs via a cyclic AMP-independent mechanism in the rat hippocampus. J. Neurosci. 15:1995;737-749.
20. Martin-Schild S., Gerall A.A., Kastin A.J., Zadina J.E. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J. Comp. Neurol. 405:1999;450-471.
21. Martin-Schild S., Zadina J.E., Gerall A.A., Vigh S., Kastin A.J. Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord. Peptides. 18:1997;1641-1649.
22. Mendelowitz D. Nicotine excites cardiac vagal neurons via three sites of action. Clin. Exp. Pharmacol. Physiol. 25:1998;453-456.
23. Mendelowitz D. Advances in parasympathetic control of heart rate and cardiac function. News Physiol. Sci. 14:1999;155-161.
24. Mendelowitz D., Kunze D.L. Identification and dissociation of cardiovascular neurons from the medulla for patch clamp analysis. Neurosci. Lett. 132:1991;217-221.
25. Neff R.A., Humphrey J., Mihalevich M., Mendelowitz D. Nicotine enhances presynaptic and postsynaptic glutamatergic neurotransmission to activate cardiac parasympathetic neurons. Circ. Res. 83:1998;1241-1247.
26. Neff R.A., Mihalevich M., Mendelowitz D. Stimulation of NTS activates NMDA and non-NMDA receptors in rat cardiac vagal neurons in the nucleus ambiguus. Brain Res. 792:1998;277-282.
27. Nomura S., Ding Y-Q., Kaneko T., Li L.I., Mizuno N. Localization of μ-opioid receptor-like immunoreactivity in the central components of the vagus nerve: a light and electron microscope study in the rat. Neurosci. 73:1996;277-286.
28. Ogura M., Kita H. Dynorphin exerts both postsynaptic and presynaptic effects in the Globus pallidus of the rat. J. Neurophysiol. 83:2000;3366-3376.
29. Pisani A., Bonsi P., Centonze D., Calabresi P., Bernardi G. Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. J. Neurosci. 20:2000;RC69.
30. Radcliffe K.A., Fisher J.L., Gray R., Dani J.A. Nicotinic modulation of glutamate and GABA synaptic transmission of hippocampal neurons. Ann. NY Acad. Sci. 868:1999;591-610.
31. Rainnie D.G. Serotonergic modulation of neurotransmission in the rat basolateral amygdala. J. Neurophysiol. 82:1999;69-85.
32. Randich A., Thurston C.L., Ludwig P.S., Robertson J.D., Rasmussen C. Intravenous morphine-induced activation of vagal afferents: peripheral, spinal, and CNS substrates mediating inhibition of spinal nociception and cardiovascular responses. J. Neurophysiol. 68:1992;1027-1045.
33. Sakurada S., Hayashi T., Yuhki M., Fujimura T., Murayama K., Yonezawa A., Sakurada C., Takeshita M., Zadina J.E., Kastin A.J., Sakurada T. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone. Brain Res. 881:2000;1-8.
34. Sala R., Viegi A., Rossi F.M., Pizzorusso T., Bonanno G., Raiteri M., Maffei L. Nerve growth factor and brain-derived neurotrophic factor increase neurotransmitter release in the rat visual cortex. Eur. J. Neurosci. 10:1998;2185-2191.
35. Sbrenna S., Marti M., Morari M., Calo G., Guerrini R., Beani L., Bianchi C. L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors. J. Pharmacol. Exp. Ther. 291:1999;1365-1371.
36. Sim L.J., Childers S.R. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5′-O-(gamma-thio)-triphosphate binding in guinea pig brain. J. Comp. Neurol. 386:1997;562-572.
37. Spyer K.M., Gilbey M.P. Cardiorespiratory interactions in heart-rate control. Ann. NY Acad. Sci. 533:1988;350-357.
38. Stanford I.M., Cooper A.J. Presynaptic mu and delta opioid receptor modulation of GABAA IPSCs in the rat globus pallidus in vitro. J. Neurosci. 19:1999;4796-4803.
39. Vaughan C.W. Enhancement of opioid inhibition of GABAergic synaptic transmission by cyclo-oxygenase inhibitors in rat periaqueductal grey neurones. Br. J. Pharmacol. 123:1998;1479-1481.
40. Vaughan C.W., Christie M.J. Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J. Physiol. 498:1997;463-472.
41. Wang J., Irnaten M., Mendelowitz D. Characteristics of spontaneous and evoked GABAergic synaptic currents in cardiac parasympathetic neurons in rats. Brain Res. 889:2001;78-83.
42. Wang J., Irnaten M., Neff R.A., Venkatesan P., Evans C., Loewy A.D., Mettenleiter T.C., Mendelowitz D. Synaptic and neurotransmitter activation of cardiac vagal neurons in the nucleus ambiguus. Ann. NY Acad. Sci. 940:2001;237-246.
43. Wu K.M., Martin W.R. An analysis of nicotinic and opioid processes in the medulla oblongata and nucleus ambiguus of the dog. J. Pharmacol. Exp. Ther. 227:1983;302-307.
44. Xia Y., Haddad G.G. Ontogeny and distribution of opioid receptors in the rat brainstem. Brain Res. 549:1991;181-193.
45. Yuan C.S., Foss J.F. Gastric effects of methylnaltrexone on mu, kappa and delta opioid agonists induced brainstem unitary responses. Neuropharmacology. 38:1999;425-432.
46. Zadina J.E., Hackler L., Ge L.J., Kastin A.J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature. 386:1997;499-502.
47. Zadina J.E., Martin-Schild S., Gerall A.A., Kastin A.J., Hackler L., Ge L.J., Zhang X. Endomorphins: novel endogenous mu-opiate receptor agonists in regions of high mu-opiate receptor density. Ann. NY Acad. Sci. 897:1999;136-144.